Adherence to treatment for hypothyroidism in pregnancy and relationship with thyrotropin control: a retrospective observational cohort study

BACKGROUND: Hypothyroidism is the second most common endocrinological disease during pregnancy, with percentages that can range between 3.2 and 5.5%. A good maternal and foetal health outcome depends on thyroid hormone replacement therapy. The goal of such therapy is to maintain thyrotropin (TSH) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Siscart, Júlia, Orós, Míriam, Serna, M. Catalina, Perejón, Dani, Galván, Leonardo, Ortega, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886742/
https://www.ncbi.nlm.nih.gov/pubmed/35232385
http://dx.doi.org/10.1186/s12884-022-04483-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886742/
https://www.ncbi.nlm.nih.gov/pubmed/35232385
http://dx.doi.org/10.1186/s12884-022-04483-8

Ejemplares similares